Navigation Links
Accuray Incorporated to Speak at 22nd Annual Oppenheimer Healthcare Conference
Date:12/5/2011

SUNNYVALE, Calif., Dec. 5, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Oppenheimer Healthcare Conference in New York City on Tuesday, December 13, 2011 at 1:00 p.m. EST/10:00 a.m. PST. 

A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com.  The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. To date, more than 200,000 patients worldwide have been treated using the company's technologies and more than 598 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.


'/>"/>
SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Accuray Receives Outstanding Innovative Improvement Award for its CyberKnife System
2. Accuray Incorporateds CEO to Speak at Lazard Capital Markets 8th Annual Healthcare Conference and Stephens Fall Investment Conference
3. Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System
4. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2012
5. Accuray Ranked 274th Fastest Growing Company in North America on Deloittes 2011 Technology Fast 500™
6. Accuray Unveils CyberKnife and TomoTherapy Product Enhancements and Service Offerings at ASTRO 2011
7. Accuray Incorporated to Speak at JMP Securities Healthcare Conference
8. Accuray Hires Chief Commercial Officer
9. Accuray Announces Results for Fourth Quarter and Fiscal Year 2011
10. Accuray Incorporated to Speak at UBS Global Life Sciences Conference
11. Accuray Extends Industry-Leading Customer Service Program to TomoTherapy Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/18/2017)... DIEGO and BLOOMINGTON, Minn. ... Inc. (NASDAQ: IMMY ) ("Imprimis"), an ... Precision Lens ("Precision Lens"), today announced the signing ... the agreement, Precision Lens will deploy a dedicated ... select geographies in the U.S., primarily focused in ...
(Date:4/18/2017)... , April 18, 2017 Research and ... the United States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast ... ... molecular imaging equipment revenues as well as growth in the ... will provide value to market participants that design and manufacture ...
Breaking Medicine Technology:
(Date:4/26/2017)... LOUIS (PRWEB) , ... April 26, 2017 , ... ... designed specifically to improve the profitability of ready-to-drink, high-protein beverages by helping beverage ... economic alternative to dairy proteins, providing direct cost savings as well as more ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus ... that’s the first in a new class of photodynamic cosmetics (PDC). , Allumera® ... skin, visibly reduce outward signs of aging, and minimize the appearance of pores ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients ... that achieves results in a fraction of the time as traditional braces – ... Significance Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
Breaking Medicine News(10 mins):